Health Catalyst (HCAT) Net Income towards Common Stockholders (2018 - 2025)
Historic Net Income towards Common Stockholders for Health Catalyst (HCAT) over the last 8 years, with Q3 2025 value amounting to -$22.2 million.
- Health Catalyst's Net Income towards Common Stockholders fell 5095.07% to -$22.2 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$107.6 million, marking a year-over-year decrease of 3591.21%. This contributed to the annual value of -$69.5 million for FY2024, which is 4119.52% up from last year.
- Latest data reveals that Health Catalyst reported Net Income towards Common Stockholders of -$22.2 million as of Q3 2025, which was down 5095.07% from -$41.0 million recorded in Q2 2025.
- Over the past 5 years, Health Catalyst's Net Income towards Common Stockholders peaked at -$13.5 million during Q2 2024, and registered a low of -$49.0 million during Q4 2021.
- Its 5-year average for Net Income towards Common Stockholders is -$29.7 million, with a median of -$30.4 million in 2023.
- Per our database at Business Quant, Health Catalyst's Net Income towards Common Stockholders skyrocketed by 5855.64% in 2024 and then tumbled by 20318.14% in 2025.
- Health Catalyst's Net Income towards Common Stockholders (Quarter) stood at -$49.0 million in 2021, then rose by 27.0% to -$35.8 million in 2022, then rose by 15.12% to -$30.4 million in 2023, then soared by 31.9% to -$20.7 million in 2024, then dropped by 7.53% to -$22.2 million in 2025.
- Its last three reported values are -$22.2 million in Q3 2025, -$41.0 million for Q2 2025, and -$23.7 million during Q1 2025.